Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Korro Bio Inc (KRRO)

Korro Bio Inc (KRRO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 114,232
  • Shares Outstanding, K 9,417
  • Annual Sales, $ 2,270 K
  • Annual Income, $ -83,580 K
  • EBIT $ -97 M
  • EBITDA $ -95 M
  • 60-Month Beta 2.99
  • Price/Sales 14.68
  • Price/Cash Flow N/A
  • Price/Book 1.15

Options Overview Details

View History
  • Implied Volatility 220.13% (+66.80%)
  • Historical Volatility 79.68%
  • IV Percentile 87%
  • IV Rank 60.73%
  • IV High 316.82% on 02/13/26
  • IV Low 70.56% on 12/11/25
  • Expected Move (DTE 17) 1.28 (11.09%)
  • Put/Call Vol Ratio 999.99
  • Today's Volume 1
  • Volume Avg (30-Day) 173
  • Put/Call OI Ratio 1.03
  • Today's Open Interest 5,353
  • Open Int (30-Day) 5,523
  • Expected Range 10.23 to 12.78

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 11 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate -1.93
  • Number of Estimates 5
  • High Estimate -1.44
  • Low Estimate -2.20
  • Prior Year -2.26
  • Growth Rate Est. (year over year) +14.60%

Price Performance

See More
Period Period Low Period High Performance
1-Month
10.81 +6.38%
on 02/12/26
13.57 -15.25%
on 02/03/26
-1.55 (-11.88%)
since 02/02/26
3-Month
5.23 +119.89%
on 12/03/25
14.94 -23.05%
on 01/29/26
+6.22 (+117.80%)
since 12/02/25
52-Week
5.20 +120.97%
on 12/02/25
55.89 -79.42%
on 10/16/25
-13.57 (-54.13%)
since 02/28/25

Most Recent Stories

More News
Korro to Present at the TD Cowen 46th Annual Health Care Conference

CAMBRIDGE, Mass., Feb. 25, 2026 (GLOBE NEWSWIRE) -- Korro Bio, Inc. (Korro) (Nasdaq: KRRO), a biopharmaceutical company developing a new class of genetic medicines based on editing RNA for rare and highly...

KRRO : 11.50 (-5.19%)
Korro to Host Virtual Analyst Day on January 27, 2026

- Program to feature presentations from the company management about  KRRO-121 for the potential treatment of hyperammonemia , a leading clinical hepatologist about ammonia-driven diseases, and a caregiver...

KRRO : 11.50 (-5.19%)
Korro to Present at the 44th Annual J.P. Morgan Healthcare Conference

CAMBRIDGE, Mass., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Korro Bio, Inc. (Korro) (Nasdaq: KRRO) today announced that Ram Aiyar, Ph.D., Chief Executive Officer and President, will present at the 44 th Annual...

KRRO : 11.50 (-5.19%)
Korro Reports Third Quarter Financial Results, Provides Updates on KRRO-110 in Alpha-1 Antitrypsin Deficiency and Additional Pipeline Programs

CAMBRIDGE, Mass., Nov. 12, 2025 (GLOBE NEWSWIRE) -- — KRRO-110 produced functional protein in Alpha-1 Antitrypsin Deficiency (AATD) patients     — KRRO-110 did not reach projected...

KRRO : 11.50 (-5.19%)
Korro Bio CFO Vineet Agarwal Resigns, Interim Appointed

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Korro Bio...

KRRO : 11.50 (-5.19%)
Piper Sandler Sticks to Their Buy Rating for Korro Bio (KRRO)

Piper Sandler analyst Yasmeen Rahimi maintained a Buy rating on Korro Bio today and set a price target of $180.00. The company’s shares closed yesterday at $45.72.Elevate Your Investing Strategy: Take...

KRRO : 11.50 (-5.19%)
Korro to Participate in Upcoming Investor and Scientific Conferences

CAMBRIDGE, Mass., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Korro Bio, Inc. (Korro) (Nasdaq: KRRO) today announced that members of management will participate in the following upcoming investor and scientific...

KRRO : 11.50 (-5.19%)
Korro Reports Second Quarter 2025 Financial Results and Provides Business Updates

—  Interim readout from Phase 1/2a REWRITE clinical trial of KRRO-110 on track for the second half of 2025 —  Completed dosing of over 80% of planned REWRITE healthy volunteers across multiple...

KRRO : 11.50 (-5.19%)
Korro to Participate in Upcoming Investor Conferences

KRRO : 11.50 (-5.19%)
Korro Reports First Quarter 2025 Financial Results and Provides Business Updates

KRRO : 11.50 (-5.19%)

Business Summary

Korro Bio Inc. is an RNA editing company focused on the discovery and development of a new class of precision genetic medicines for both rare and highly prevalent diseases. Korro Bio Inc., formerly known as Frequency Therapeutics Inc., is based in LEXINGTON, Mass.

See More

Key Turning Points

3rd Resistance Point 12.15
2nd Resistance Point 11.98
1st Resistance Point 11.74
Last Price 11.50
1st Support Level 11.33
2nd Support Level 11.16
3rd Support Level 10.92

See More

52-Week High 55.89
Fibonacci 61.8% 36.53
Fibonacci 50% 30.55
Fibonacci 38.2% 24.57
Last Price 11.50
52-Week Low 5.20

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar